BioSpace News Archive

Progenity, Inc., a biotechnology company with an established track record of success in developing and commercializing molecular testing products, announced that it will report second quarter 2020 financial results on Thursday, August 13, 2020.

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, reported its financial results for second quarter ended June 30, 2020 and provided a corporate update.

CV Sciences, Inc., a preeminent supplier and manufacturer of hemp cannabidiol products, announced its financial results for the quarter ended June 30, 2020.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on the health security market, reported financial results for the three and six months ended June 30, 2020.

Trevi Therapeutics, Inc. announced that management will host a conference call and live audio webcast at 4:30 p.m. ET on August 13, 2020, to provide a corporate update and review the Company’s financial results for the second quarter ended June 30, 2020.

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced it has entered into a definitive agreement with its Italian distributor to transition to a direct sales force in that market, effective August 1, 2020.

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced its financial results for the second quarter ended June 30, 2020.

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and six months ended June 30, 2020.

Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, reported financial results for second quarter 2020 and provided a business update.

CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the second quarter and six months ended June 30, 2020.